Search Results - "Ellegard, S."

Abstract P2-13-06: Long term clinical follow up of real world HER2-positive patients since the introduction of trastuzumab by Ellegard, S, Asowed, M, Engvall, K, Hallbeck, A-L, Elander, N, Stål, O

“…Background: The prognosis for patients with HER2-positive early breast cancer (EBC) has improved dramatically since the introduction of adjuvant trastuzumab…”
Get full text

PP057-MON: Results of Eras Protocols in Colorectal Surgery by Haldun Gundogdu, R, Eren Ersoy, P, Ellegård, S, Yazicioglu, O, Sayin, T, Nasrullayev, O

Get full text

125P Components of the PI3K/Akt pathway as prognostic factors in metastatic HER2-positive breast cancer treated with trastuzumab by Veenstra, C., Ellegard, S., Perez-Tenorio, G., FagerstrOm, V., Garsjo, J., Briedis, K., Sundqvist, M., MalmstrOm, A., Wingren, S., Stai, O.

Get full text

125P Components of the PI3K/Akt pathway as prognostic factors in metastatic HER2-positive breast cancer treated with trastuzumab by Veenstra, C., Ellegård, S., Pérez-Tenorio, G., Fagerström, V., Gårsjö, J., Briedis, K., Sundqvist, M., Malmström, A., Wingren, S., Stål, O.

Get full text